Literatur
-
1
Huber R M, Stratakis D F.
Molecular Oncology - Perspectives in Lung Cancer.
Lung Cancer.
2004;
45 Suppl 2
209-213
-
2
Fischer J R, Haffner U, Dietrich G. et al .
Drittlinientherapie mit Gefitinib beim nicht-kleinzelligen Bronchialkarzinom.
Pneumologie.
2005;
59
321-327
-
3
Herbst R S, Giaccone G, Schiller J H. et al .
Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: a Phase III Trial-INTACT 2.
J Clin Oncol.
1-3-2004;
22 (5)
785-794
-
4
Giaccone G, Herbst R S, Manegold C. et al .
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non-Small-Cell Lung Cancer: a Phase III Trial-INTACT 1.
J Clin Oncol.
1-3-2004;
22 (5)
777-784
-
5
Meert A P, Martin B, Delmotte P. et al .
The Role of EGF-R Expression on Patient Survival in Lung Cancer: a Systematic Review With Meta-Analysis.
Eur Respir J.
2002;
20 (4)
975-981
-
6
Kim K S, Jeong J Y, Kim Y C. et al .
Predictors of the Response to Gefitinib in Refractory Non-Small Cell Lung Cancer.
Clin Cancer Res.
15-3-2005;
11 (6)
2244-2251
-
7
Fukuoka M, Yano S, Giaccone G. et al .
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer (The IDEAL 1 Trial) [Corrected].
J Clin Oncol.
15-6-2003;
21 (12)
2237-2246
-
8
Shepherd F A, Pereira J, Ciuleanu T E. et al .
A randomized placebo-controlled trial of Erlotinib in patients with advanced non-small cell lung cancer (NSCLC) following failure of 1st line or 2nd line chemotherapy. A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial.
Proc ASCO.
2004;
23
(Abst. 7022)
-
9
Kobayashi S, Boggon T J, Dayaram T. et al .
EGFR Mutation and Resistance of Non-Small-Cell Lung Cancer to Gefitinib.
N Engl J Med.
24-2-2005;
352 (8)
786-792
-
10
Pao W, Miller V A, Politi K A. et al .
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated With a Second Mutation in the EGFR Kinase Domain.
PLoS Med.
2005;
2 (3)
e73
Prof. Dr. med. Rudolf M. Huber
Pneumologie · Klinikum der Universität München - Innenstadt
Ziemssenstraße 1
80336 München
Email: pneumologie@med.uni-muenchen.de
